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Abstract: Ochratoxins, and particularly ochratoxin A (OTA), are toxic fungal-derived contaminants 
of food and other agricultural products. Growing evidence supports the degradation of OTA by 
chemical, enzymatic and/or microbial means as a potential approach to remove this mycotoxin from 
food products. In particular, hydrolysis of OTA to ochratoxin α (OTα) and phenylalanine is the 
presumptive product of degradation in most cases. In the current study, we employed the zebrafish 
(Danio rerio) embryo, as a model of vertebrate development to evaluate, the teratogenicity of OTA 
and OTα. These studies show that OTA is potently active in the zebrafish embryo toxicity assay 
(ZETA), and that toxicity is both concentration- and time-dependent with discernible and quantifiable 
developmental toxicity observed at nanomolar concentrations. On the other hand, OTα had no 
significant effect on embryo development at all concentrations tested supporting a decreased 
toxicity of this degradation product. Taken together, these results suggest that ZETA is a useful, and 
highly sensitive, tool for evaluating OTA toxicity, as well as its degradation products, toward 
development of effective detoxification strategies. Specifically, the results obtained with ZETA,  
in the present study, further demonstrate the toxicity of OTA, and support its degradation via 
hydrolysis to OTα as an effective means of detoxification. 
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1. Introduction 
Ochratoxins are a family of mycotoxins produced by several fungal genera, including Penicillium 
and Aspergillus, and associated with contamination of various foods (e.g., fruits, grains, meats) and 
other agricultural products (e.g., wine, coffee) [1]. In particular, ochratoxin A (OTA; Figure 1) is, by far, 
the most prevalent, and generally considered the most toxic, variant of the family [2]. Structurally 
speaking, OTA is a chlorinated dihydroisocoumarin specifically linked, via an amide-bond, to 
phenylalanine. Toxicologically, OTA has been particularly linked to nephrotoxicity, and although 
found to a lesser extent in other tissues, it has been suggested [3,4] that specific transporters may be 
involved in the high accumulation of the toxin in kidneys. Consequently, exposure to OTA manifests 
in a recognized and well-described nephropathy, particularly in certain livestock [5]. Several studies 
have implicated oxidative stress in the toxicity of OTA including, in particular, a role of the nuclear 
factor, Nrf2 [4,6,7]. In addition to nephrotoxicity, however, other studies have indicated that OTA is 
carcinogenic via both genotoxic and non-genotoxic mechanisms [4,8–11]. Notably, ochratoxins have 
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been proposed to be involved in so-called Balkan Endemic Nephropathy, an interstitial  
nephritis—progressing to cancer in about 50% of cases—that is limited geographically to rural 
farming communities along the Danube River [12–14]. Despite demonstrated toxicity in various 
animal models with respect to nephrotoxicity and carcinogenicity, a link to human health remains, 
in fact, unconfirmed [4]. 
Several recent studies have investigated the possibility of chemical, enzymatic or microbial 
degradation of OTA as a means of detoxification in food and agricultural products [15]. It has been 
observed, for example, that OTA (as a contaminant of grains and other feeds) is effectively eliminated 
by microflora—and particularly protozoans—of ruminants, and is not, consequently, found in milk 
of these exposed animals [16], whereas non-ruminants, including humans, can transfer the toxin to 
milk [17,18]. These and other studies, therefore, suggest a role of microbial degradation of the toxin; 
in fact, numerous studies have identified OTA-degrading bacteria, fungi and protozoans as recently 
reviewed by Abrunhosa et al. [19]. Specifically, the primary pathway of enzymatic degradation 
expected and, indeed, observed in studies [19–21] is the hydrolytic cleavage of the amide bond within 
OTA, resulting in the production of so-called ochratoxin α (OTα), and phenylalanine (Figure 1). 
Several studies have indicated that OTα is relatively less toxic in various models including both  
cell-based [22] and animal models [21], and suggest that this pathway for chemical degradation of 
OTA represent an effective means of detoxification.  
The present study specifically employed the zebrafish (Danio rerio) embryo, as a vertebrate 
model of teratogenicity (i.e., developmental toxicity), to evaluate both OTA and its presumptive 
degradation product, OTα. The zebrafish system has emerged as an important toxicological model, 
and embryonic stages, in particular, present numerous scorable endpoints (e.g., morphological 
deformities, hatching, behavioral responses) relevant to evaluation of teratogenicity. Accordingly, 
the zebrafish embryo toxicity assay (ZETA) has been effectively utilized in various forms to 
investigate a wide range of environmental contaminants, including microbial toxins [23]. Moreover, 
as a well characterized vertebrate system, ZETA can, thereby, be employed as a proxy for understanding 
potential toxicity to higher animals including humans. As such, evaluation of the teratogenicity of 
OTA and OTα represents a step toward further understanding the proposed microbial/chemical 
degradation pathway as a means of detoxifying ochratoxins. 
 
Figure 1. Hydrolysis of the amide bond in OTA (1) to yield OTα (2) and phenylalanine as considered 
the primary degradation/detoxification pathway for ochratoxins. 
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2. Experimental Section 
2.1. Chemicals 
Ochratoxin A was purchased from a commercial source (Sigma-Aldrich, St. Louis, MO, USA). 
Ochratoxin α was synthesized by hydrolysis of OTA as modified from Xiao et al. [24]. Briefly,  
OTA (1.7 mg) was refluxed in 6 N HCl (6 mL) for 72 h, and liquid-liquid extraction with chloroform 
was used to recover the product (0.5 mg of presumptive OTα) of the hydrolysis. The hydrolysis 
reaction was followed by normal-phase thin-layer chromatography (TLC) using toluene/EtOAc/90% 
formic acid (5:4:1) as a solvent system [25], and fluorescence under long-wave UV (i.e., 366 nm) for 
detection; the identity of OTα was subsequently confirmed by previously described HPLC-FL and 
LC-MS methods [26,27] using a commercially available analytical standard of OTα (Romer Labs, 
Union, MO, USA). All other chemicals and reagents were purchased from either VWR Scientific 
(Radnor, PA, USA), or Sigma-Aldrich (St. Louis, MO, USA). 
2.2. Zebrafish Embryo Toxicity Assay 
The zebrafish embryo teratogenicity assay (ZETA) was generally conducted as previously 
described [23]. Briefly, chemical treatments (as MeOH solution in minimal volumes), along with 
solvent (i.e., MeOH) controls, were added in triplicate to wells of 24-well polypropylene plates 
(Evergreen Scientific, Los Angeles, CA, USA), and allowed to evaporate to dryness. Subsequently,  
1 mL of E3 medium [28] was added to each well, and five zebrafish embryos (≤2 hours post-fertilization 
[hpf], 4–32 cell stage) were transferred to each test well. Compounds were tested at a range of 
concentrations (based on preliminary studies) from 0.05 to 2.5 µM; specifically, OTA was tested at 
0.05, 0.1, 0.25, 0.5, 1, 2 and 2.5 µM, whereas OTα was tested at 0.1, 0.25, 0.5, 1 and 2.5 µM due to 
relatively limited amount of compound. Embryos were subsequently observed daily using a 
dissecting microscope until 5 days post-fertilization (dpf) when hatching of eleutheroembryos was 
typically completed, and prior to larval stages (i.e., ≥7 dpf). All breeding and bioassays involving 
zebrafish were conducted under protocols approved by the FIU Institutional Animal Care and Use 
Committee (IACUC), and performed by trained investigators. 
2.3. Data Analysis 
Percent mortality was calculated for each replicate (n = 3), and relative teratogenicity was, 
likewise, calculated as the percent deformed embryos per total number of live embryos in each replicate, 
for both OTA and OTα at each test concentration (see Section 2.2.) and each daily observation time 
point (1, 2, 3, 4 and 5 dpf). Relative mortality and developmental toxicity at each observational time 
point was calculated, respectively, as concentration for 50% lethality (LC50), and effective concentration 
(EC50) for teratogenicity, using GraphPad software (La Jolla, CA, USA). Relative (i.e., average) 
mortality and development toxicity at each concentration and observational time point was evaluated 
by analysis of variance (ANOVA) using AnalystSoft software (Walnut, CA, USA) to determine statistical 
significance relative to negative (i.e., untreated embryo) controls. 
3. Results and Discussion 
3.1. Synthesis of OTα by Hydrolysis of OTA 
Ochratoxin α as the presumptive degradation product of OTA was synthesized by the 
previously described hydrolysis [24]. The reaction was evaluated by HPLC-FL and LC-MS to confirm 
hydrolysis (and presence of OTα. These analyses suggest essentially complete hydrolysis of OTA to 
OTα (Figure 2). The identity of the hydrolysis product was confirmed by mass spectrometry (i.e.,  
LC-MS), specifically based on the observation of the OTA molecular ion (MH+ 255 m/z), and mass 
transition of the precursor to daughter (255 > 211 m/z), as well as comparison to a reference standard 
of OTα (Figure 2). Notably, a small amount of OTα was also observed in the standard of OTA as a 
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presumptive degradation product. The resulting OTα (i.e., hydrolysis product) was used for 
subsequent comparative toxicology studies. 
 
Figure 2. Chromatogram (HPLC-FL) of the hydrolysis of OTA to OTα. Shown are OTA standard (A), 
and subsequent hydrolysis product (B); for comparison, the chromatogram of the reference standard 
of OTα (C) as the presumptive hydrolysis product is shown. The identity of hydrolysis product was 
confirmed as OTα by LC-MS (see inset for pane (B)) based on the molecular ion (MH+ 255 m/z, Full Scan) 
and Selected Reaction Monitoring (SRM) mass transition (255 > 211 m/z). Apparent degradation to 
OTα was also observed in the OTA standard (see (A)).  
3.2. Teratogenicity of OTA and OTα 
Ochratoxin A and its presumptive degradation product, OTα were evaluated for teratogenicity 
by ZETA. Consistent with toxicity in other models, OTA was potently toxic to zebrafish embryo 
development (Figures 3–5). Embryos exposed to concentrations as low as 1 µM developed 
abnormally with frequencies significantly higher than controls by 1 dpf (Figure 3). This development 
toxicity increased progressively at subsequent time-points (e.g., 2, 4 and 5 dpf) observed.  
For example, all embryos exposed to OTA were discernibly deformed at concentrations of 1, 0.25 and 
0.1 µM by 2, 4 and 5 dpf, respectively, and significant teratogenicity was, furthermore, observed at 
even the lowest concentration tested (0.05 µM) by 5 dpf (Figure 3). Notably, no difference was 
observed between 2 and 3 dpf (data not shown). Likewise, EC50 values for teratogenicity of OTA 
decreased over exposure time from 1 to 5 dpf, respectively, from 0.25 to 0.02 µM. 
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Figure 3. Dose and time dependence of OTA and OTα teratogenicity in ZETA. Shown are averages 
and standard deviations (n = 3) of the percent deformed embryos (5 per well/replicate) at a range of 
concentrations at 1 (A), 2 (B), 4 (C) and 5 (D) days post-fertilization. Activity is statistically compared 
to solvent (i.e., “MeOH”) only controls (n = 3); statistically significant differences are indicated at:  
(a) p < 0.05; (b) p < 0.01; and (c) p < 0.005. No significant difference was observed between MeOH-only 
and untreated (“E3” i.e., test medium alone) controls as shown. 
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Figure 4. Representative development dysfunction of zebrafish embryos exposed to OTA and OTα at 
1 and 3 days post-fertilization. Shown are embryos exposed to 0.5 µM OTA (A) compared to  
solvent (i.e., MeOH) only controls (B) at 1 dpf; and embryos exposed to 0.5 µM (C) and 0.1 µM (D) 
OTA, and 2.5 µM OTα (E), compared to solvent, i.e., MeOH, only controls (F), at 3 dpf. 
Developmental dysfunction of zebrafish exposed to OTA was characterized by discernible 
deformities, reduced growth and hatching rates, and lethality. At the highest concentrations (≥0.5 µM), 
OTA was generally lethal by 2 dpf, and development of surviving embryos was severely retarded 
(Figure 4). At concentrations as low as 0.05 µM, clear morphological deformities were observed by 
4–5 dpf, specifically characterized by reduced growth rates, craniofacial deformities, curvature of the 
body axis and edemas (Figure 5), as well as a dose-dependent reduction in hatching rates (Figure 6). 
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Figure 5. Representative development dysfunction of zebrafish embryos exposed to OTA and OTα at 
5 days post-fertilization. Shown are embryos exposed to 0.5 µM (A), 0.25 µM (B), 0.1 µM (C) and  
0.05 µM (D) OTA, as well as 2.5 µM OTα (E), compared to solvent-only (i.e., MeOH) controls (F).  
Teratogenicity of OTA in the present study quantitatively and qualitatively resembles that 
previously observed. In prior, non-peer reviewed reports [29], developmental toxicity in the zebrafish, 
including edemas and malformation of fins and eyes, was observed at concentrations as low 0.6 µM 
and 0.2 µM by 2 and 6 dpf, respectively. More generally, dose and time dependence of teratogenicity 
has been previous observed in other models [2,30]. Similar to the zebrafish, OTA was found, for 
example, in the amphibian, i.e., Xenopus laevis, model (i.e., “Fetal Embryo Toxicity Assay Xenopus” 
(FETAX)), to be teratogenic, specifically resulting in various craniofacial deformities [2] as observed 
in the present study. This manifestation of developmental toxicity (i.e., craniofacial deformities) has, 
in fact, been observed in a wide range of vertebrate models including rats [31], mice [32], hamsters [33] 
and chicken [30]. Studies in the FETAX system suggest EC50 values of approximately 60 nM compared 
to discernible developmental toxicity at levels <20 nM in ZETA. Moreover, the numerous practical 
advantages of the zebrafish model (e.g., high fecundity, completely sequenced genome, high-throughput 
potential, etc.), along with this sensitivity, suggest that ZETA is a powerful toxicological system for 
evaluating toxicity of OTA and its metabolites (and other degradation products). 
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Figure 6. Effect of OTA on zebrafish hatching rate. Shown, for a representative exposure, is percent 
unhatched eggs/embryos at 5 days post-fertilization for 0.25, 0.1 and 0.05 µM OTA compared to 
solvent only (“MeOH”) and solvent-free medium (“E3”). At OTA > 0.25 µM, all embryos were dead 
or severely deformed (and not hatched). Error bars represent standard deviations (n = 2). 
Compared to teratogenicity, significant lethality was observed at higher concentrations of OTA, 
and later stages of development (Figure 7). No statistically significant mortality was observed at  
1 dpf, although slightly higher average mortalities were observed at the highest concentrations (1–2.5 µM) 
of the toxin. By 2 dpf, however, significant mortality among embryos exposed to OTA was observed 
at concentrations as low as 0.5 µM OTA. Percent mortality, however, at later stages (4 and 5 dpf) did 
not increase (data not shown), and significant mortality was not observed during the course of 
exposures at the lower test concentrations (≤0.25 µM) despite significantly higher rates of deformity 
in these treatments. In fact, calculated LC50 values were nearly an order of magnitude greater than 
effective concentrations (i.e., EC50) for developmental deformities at, for example, both 1 dpf (2.14 and 
0.25 µM, respectively) and 4 dpf (0.25 and 0.03 µM, respectively). 
Taken together, these results generally support a high (i.e., nanomolar concentration) sensitivity 
of zebrafish teratogenicity (compared to lethality) as a toxicological marker for OTA toxicity, and 
therefore, a potentially important utility of this biological system for future studies. Indeed, the 
observed sensitivity of ZETA (e.g., EC50 ≥ 20 nM) approaches the current regulatory food safety limits 
for OTA including, for example, European Union limits set for various agricultural and food products 
which are typically in the range of 1–80 ppb, i.e., ~2.5 to 200 nM [34]. 
In contrast to OTA, embryos exposed to OTα showed neither teratogenicity, nor mortality, 
significantly different from that of negative controls (i.e., solvent only, untreated) over 5 dpf. 
Generally speaking, an average of 19% frequency of deformity was observed for all concentrations 
tested (≤2.5 µM), and exposure/developmental times (1–5 dpf) evaluated, for OTα-exposed embryos, 
corresponding to <1 discernibly deformed embryo out of 5 tested per replicate (n = 3), which was not 
significantly different from either solvent (i.e., MeOH) only control, or untreated, embryos (Figure 3). 
Furthermore, no concentration or time-dependent trends were observed for embryos exposed to  
OTα (Figure 3). Similar to deformity, no significantly different percent mortalities were observed over 
range of concentrations tested at any observational time points for OTα compared to controls (Figure 7). 
Taken together, these finding suggest that hydrolysis of OTA to OTα, as the presumptive degradation 
product of OTA (discussed below), effectively detoxifies the compound with respect to teratogenicity 
and mortality in ZETA. 
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Figure 7. Dose and time dependence of OTA and OTα lethality in ZETA. Shown are averages and 
standard deviations (n = 3) of the percent mortality (5 per well/replicate) at a range of concentrations 
at 1 (A), 2 (B) and 3 (C) days post-fertilization. Activity is statistically compared to solvent (i.e., MeOH) 
only controls (n = 3); statistically significant difference are indicated at: (a) p < 0.05; (b) p < 0.01; and  
(c) p < 0.005. No significant difference was observed between MeOH-only and untreated (i.e., E3 test 
medium alone) controls as shown. 
Several previous studies have investigated the potential degradation of OTA via chemical, 
enzymatic or microbial metabolic means [19], specifically as a means of removing the toxin from 
agricultural products. Generally speaking, these studies have indicated that hydrolysis of OTA to 
OTα and phenylalanine (Figure 1) is the most likely, and most frequently observed, degradation 
pathway [19–21]. Recently, for example, employing the bacterial species Cupriavidus basilensis, 
Ferenczi et al. [21] demonstrated apparent hydrolysis of OTA to OTα, and consequent detoxification 
as evidenced by comparative toxicological studies in a mouse model of nephrotoxicity. Indeed, about 
16 species of bacteria are known to have OTA-degrading capability, along with protozoans, yeasts 
and filamentous fungi and even some plants [19–21]. In essentially all cases in which degradation 
was characterized, cleavage of the amide bond to produce OTα and phenylalanine (Figure 1) was 
reported. The enzymes responsible for the hydrolytic cleavage have, however, varied and included, 
carboxypeptidases, protease and even lipases [19]. 
Although the present results suggest that hydrolysis of OTA to OTα is an effective means of 
detoxification, several studies have, in fact, suggested alternative degradation routes for OTA [19,35–37].  
In particular, a hypothetical degradation via opening of the lactone ring has been proposed [35,37], 
and studies demonstrated toxicity of the open-ring OTA in a rats, although similar toxicity of the 
proposed degradation product in other mammal (i.e., mouse) models—as well as other biological 
activity (i.e., antibacterial)—was not observed [37]. Most recently, an amide of OTα was observed, 
following light and heat treatment of OTA; however, similar to OTα, the amide was also found to be 
generally non-toxic in cell-based assays [36]. That said, continued evaluation of metabolic products, 
and specifically the toxicity of the products of chemical or enzymatic degradation, is needed. 
9 
Toxins 2016, 8, 40 
4. Conclusions 
The results presented here suggest that the zebrafish is an effective model for evaluating toxicity 
of OTA and degradation products. Teratogenicity was observed at sub-micromolar concentrations 
with EC50 as low as 20 nM. This teratogenicity is quantitatively and qualitatively consistent with that 
observed in other animal models, but at lower effective concentrations. Along with numerous 
practical advantages of zebrafish, these findings support the utility of ZETA, as a rapid, sensitive and 
highly informative tool, for investigating toxicity of OTA and its degradative products. 
Specifically, the present study confirms, as per previous studies, that OTA is acutely toxic, but 
its presumptive degradation product, OTα is generally not toxic. This finding, therefore, further 
supports these strategies for detoxifying OTA as a food contaminant. However, continued investigation 
of alternative degradation pathways is needed, and the ZETA system will be a useful tool to this end. 
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